myelodysplastic syndromes (MDS) | Page 4 | Aplastic Anemia & MDS International Foundation

myelodysplastic syndromes (MDS)

Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 Abnormalities

Author(s): 
Sallman DA, Barnard J, Al Ali NH, Garcia-Manero G, Sekeres MA, DeZern A, Steensma DP, Roboz G, Jabbour E, Maciejewski JP, Pierce S, Padron E, Lancet JE, Kantarjian H, List AF, Komrokji RS
Primary Author: 
Sallman DA
Journal Title: 
Clinical Lymphoma , Myeloma & Leukemia
Original Publication Date: 
Mar 2020

BACKGROUND:

Bone Marrow Diseases: 

SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM)

Author(s): 
Malcovati L, Stevenson K, Papaemmanuil E, Neuberg D, Bejar R, Boultwood J, Bowen DT, Campbell PJ, Ebert BL, Fenaux P, Haferlach T, Heuser M, Jansen JH, Komrokji RS, Maciejewski JP, Walter MJ, Fontenay M, Garcia-Manero G, Graubert
Primary Author: 
Malcovati L
Journal Title: 
Blood
Original Publication Date: 
Apr 2020

The 2016 revision of the World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues is characterized by a closer integration of morphology and molecular genetics. Notwithstanding, the myelodysplastic syndrome (MDS) with isolated del(5q) remains so far the only MDS subtype defined by a genetic abnormality.

Bone Marrow Diseases: 

2020 Patient & Family Virtual Conference

About

Due to the coronavirus (COVID-19) pandemic, AAMDSIF made the decision to move our conferences online in order to protect the health of our patients, families, caregivers and faculty.

We would like to acknowledge the support of our many generous patients, families and caregivers as well as our corporate partners including Celgene, Alexion, Novartis, Genentech, Jazz Pharmaceuticals, Apellis and Acceleron.

Event Date: 
Sat, 04/25/2020
Conference Event Type: 

National Conference 2020 Virtual March for Marrow

We've gone VIRTUAL!
In light of the spread of the Coronavirus (COVID-19) and with the health and well-being of our patients, family members, friends and faculty as our top priority, AAMDSIF has decided to hold our March for Marrow as a VIRTUAL WALK! 

Event Date: 
Sat, 07/18/2020
Community Event Type: 

Barry Skikne, MD

Skikne, Barry
Hematologist
Westwood Medical Pavilion and the Richard and Annette Bloch Cancer Care Pavilion

Dr. Barry Skikne is certified by the American Board of Internal Medicine with a subcertification in hematology. He completed a fellowship at the University of Kansas Medical Center. He earned his medical degree from the University of Witwatersrand and completed his residency at Johannesburg Hospital.